Female nurse holding iPad while conversing with male patient

Genentech Patient Support Services for Ophthalmology Is Here to Help

When your doctor prescribes a Genentech Ophthalmology treatment, we have programs that can help based on your unique needs.

Use our Patient Assistance Tool to find out what you might be eligible for

Several options are available that may help you with the out-of-pocket costs of SUSVIMO.

Find the right patient assistance option for you by using the Patient Assistance Tool.

Do you have health insurance?
Does your health insurance cover your Genentech treatment?
Do you have commercial health insurance?
Are you already getting financial assistance to help pay for your treatment?
Are you taking SUSVIMO for an FDA-approved use?

You Might Qualify for a Referral to the Genentech Ophthalmology Co-pay Program

If you have commercial health insurance, SUSVIMO Access Solutions can refer you to the Genentech Ophthalmology Co-pay Program. It can help you with the out-of-pocket costs of your Genentech treatment, if you’re eligible.*

Learn More

*Eligibility criteria apply. Not valid for patients using federal or state government programs to pay for their medicine and/or administration of their Genentech medicine. Patients must be taking the Genentech medicine for an FDA-approved indication. Please visit the Co-pay Program website for the full list of Terms and Conditions.

You Might Qualify for a Referral to an Independent Co-pay Assistance Foundation

If you need help with your co-pay for your Genentech treatment, we can refer you to an independent co-pay assistance foundation.*

Learn More

*Independent co-pay assistance foundations have their own rules for eligibility. Genentech has no involvement or influence in independent foundation decision-making or eligibility criteria and does not know if a foundation will be able to help you. We can only refer you to a foundation that supports your disease state. Genentech does not endorse or show preference for any particular foundation. The foundations we refer you to may not be the only ones that might be able to help you.

You Might Qualify for a Referral to the Genentech Patient Foundation

The Genentech Patient Foundation provides free Genentech treatment to people who don't have health insurance coverage or who have financial concerns and meet eligibility criteria.*

Learn More

*If you have health insurance, you should try to get other types of financial assistance, if available. You also need to meet income requirements. If you do not have insurance, or if your insurance does not cover your Genentech treatment, you must meet a different set of income requirements. Genentech reserves the right to modify or discontinue the program at any time and to verify the accuracy of information submitted.

There may be options to help you pay for your Genentech Ophthalmology treatment:

Genentech Ophthalmology Co-pay Program*

The Genentech Ophthalmology Co-pay Program helps eligible patients who have commercial health insurance^‡ with the out-of-pocket costs for SUSVIMO.

LEARN ABOUT THE CO-PAY PROGRAM

Independent co-pay assistance foundations^†

If you need help with the co-pay for your Genentech Ophthalmology treatment, Genentech Ophthalmology Access Solutions can refer you to an independent co-pay assistance foundation. This is a charitable organization that gives financial assistance for treatments.

SEE HOW WE CAN HELP WITH THE CO-PAY

The Genentech Patient Foundation^§

If you don’t have insurance coverage or have financial concerns and meet eligibility criteria, you may be able to get free treatment from the Genentech Patient Foundation.

SEE IF YOU QUALIFY FOR FREE TREATMENT

Have questions or need assistance? Just call (833) EYE-GENE/(833) 393-4363 and one of our representatives will be with you soon. Our representatives are available Monday–Friday, 9 am to 8 pm Eastern Time.

^†Independent co-pay assistance foundations have their own rules for eligibility. We cannot guarantee a foundation will help you. We only can refer you to a foundation that supports your disease state. We do not endorse or show financial preference for any particular foundation. The foundations we refer you to are not the only ones that might be able to help you.

^‡This might be a plan you get through your employer or one you purchased through a Health Insurance Marketplace like HealthCare.gov.

^§If you have health insurance, you should try to get other types of financial assistance, if available. You also need to meet income requirements. If you do not have insurance, or if your insurance does not cover your Genentech Ophthalmology treatment, you must meet a different set of income requirements. Genentech reserves the right to modify or discontinue the program at any time and to verify the accuracy of information submitted.

What is SUSVIMO (ranibizumab injection)?

SUSVIMO is a prescription medicine used to treat adults with neovascular (wet) Age‑related Macular Degeneration (AMD) who have responded to at least two injections of a Vascular Endothelial Growth Factor (VEGF) inhibitor in the gel-like part of the eye (intravitreal). It is not known if SUSVIMO is safe and effective in children.

What is the most important information I should know about SUSVIMO?

SUSVIMO (ranibizumab injection) is delivered into the eye using the SUSVIMO implant. The SUSVIMO implant and the procedures to insert, fill, refill, and remove the eye (ocular) implant can cause serious side effects, including:

An eye infection (endophthalmitis). Endophthalmitis is an infection of the eyeball that can cause permanent damage to your eye, including blindness. Call your healthcare provider right away if you have increasing eye pain, vision loss, sensitivity to light, or redness in the white of the eye. Endophthalmitis requires urgent (same-day) medical or surgical treatment
A missing layer on top of the white part of the eye (conjunctival erosion). Conjunctival erosion is an area that becomes missing (defect) in the layer (conjunctiva) that covers the white part of the eye, which may result in exposure of the implant. Call your healthcare provider right away if you have a sudden feeling that something is in your eye, eye discharge, or watering of the eye. Conjunctival erosion may require surgical treatment
An opening of the layer that covers the white part of the eye (conjunctival retraction). Conjunctival retraction is an opening or gaping in the layer (conjunctiva) that covers the white part of the eye, which may cause the implant to be exposed. Call your healthcare provider right away if you have a sudden feeling that something is in your eye, eye discharge, or watering of the eye. Conjunctival retraction may require surgical treatment

Do not receive SUSVIMO if you:

Have an infection in or around your eye
Have active swelling around your eye that may include pain and redness
Are allergic to ranibizumab or any of the ingredients in SUSVIMO

Talk to your healthcare provider before receiving SUSVIMO if you have any of these conditions.

Before receiving SUSVIMO, tell your healthcare provider about all of your medical conditions, including if you:

Are currently taking or have recently taken medicines that lower the chance of blood clots forming in the body, such as warfarin, low or regular doses of aspirin, or nonsteroidal anti-inflammatory drugs (NSAIDs)
Are pregnant or plan to become pregnant. It is not known if SUSVIMO will harm your unborn baby. You should use birth control during your treatment with SUSVIMO and for 12 months after your last dose of SUSVIMO

What are other possible side effects of SUSVIMO?

The SUSVIMO implant and the procedures to insert, fill, refill, and remove the eye (ocular) implant can cause other serious side effects, including:

Tear and separation of layers of the retina (rhegmatogenous retinal detachment). Rhegmatogenous retinal detachment is a tear and separation of one of the layers of the retina in the back of the eye that senses light. Call your healthcare provider or go to the emergency room right away if you see flashing lights, see a curtain or veil covering part of your vision, or have a change in, or a loss of, vision. Rhegmatogenous retinal detachment requires surgical treatment
Implant movement (implant dislocation): Tell your healthcare provider right away if you notice that the implant has moved out of place. This movement may require surgical treatment to correct
Implant damage: Damage to the implant that prevents continued treatment (refills) with SUSVIMO. If the implant is not able to be properly refilled, your wet AMD may be inadequately treated and your physician may remove the implant and/or change your treatment
Bleeding (vitreous hemorrhage): Vitreous hemorrhage is bleeding within the gel-like substance (vitreous) inside of your eye. Call your healthcare provider right away if you have an increase in moving spots or what looks like spider webs in your vision, as you may need an additional eye surgery
Bump on top of the white layer of the eye (conjunctival bleb): Conjunctival bleb is a small bulge in the layer (conjunctiva) that covers the white part of the eye where the implant is inserted. This may be due to leakage of fluid from the inside of the eye. Call your healthcare provider right away if you have a sudden feeling that something is in your eye (foreign body sensation), see a bulge over the white part of your eye, have eye discharge, or have watering in the eye. You may need medical or surgical treatment
Temporary decrease in vision after the SUSVIMO procedure

The most common side effects of SUSVIMO include:

Blood on the white of the eye
Eye pain
Redness in the white of the eye
Sensitivity to light

These are not all the possible side effects of SUSVIMO.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.

Please see Important Safety Information, including Serious Side Effects, as well as the SUSVIMO full Prescribing Information and Medication Guide.